![Martin Diggle](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Martin Diggle
Director/Board Member at
PROTEOME SCIENCES PLC
Profile
Martin Henry Diggle founded Vulpes Investment Management Ltd., where he is working as Director & Partner from 2015.
Mr. Diggle also currently works at Vulpes Life Sciences Fund, as Chairman, Proteome Sciences Plc, as Non-Executive Director from 2014, Oxford BioDynamics Plc, as Non-Executive Director from 2026, and Vulpes Ventures, as Portfolio Manager.
Mr. Diggle also formerly worked at Oxford Biomedica Plc, as Non-Independent Non-Executive Director from 2012 to 2021, Brunswick UBS, as Director & Partner, Scancell Holdings Plc, as Non-Executive Director, Leucid Bio Ltd., as Director, and Chronos Therapeutics Ltd., as Non-Executive Director.
Mr. Diggle received his graduate degree from the University of Oxford.
Martin Diggle active positions
| Companies | Position | Start |
|---|---|---|
| PROTEOME SCIENCES PLC | Director/Board Member | 15/10/2014 |
| OXFORD BIODYNAMICS PLC | Director/Board Member | 14/04/2026 |
Vulpes Investment Management Ltd.
 Vulpes Investment Management Ltd. Investment ManagersFinance Provides investment advice | Director/Board Member | 26/03/2015 |
Vulpes Investment Management Pte Ltd. (Venture Capital)
 Vulpes Investment Management Pte Ltd. (Venture Capital) Investment ManagersFinance Vulpes Ventures invests in companies located in Southeast Asia, Australia and New Zealand. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements. | Private Equity Investor | - |
Vulpes Life Sciences Fund
 Vulpes Life Sciences Fund Investment Trusts/Mutual FundsMiscellaneous Acts as Hedge Fund | Chairman | - |
Former positions of Martin Diggle
| Companies | Position | End |
|---|---|---|
| OXFORD BIOMEDICA PLC | Director/Board Member | 02/02/2021 |
Brunswick UBS
 Brunswick UBS Investment Banks/BrokersFinance Operates as a investment bank | Director/Board Member | 31/12/2002 |
Leucid Bio Ltd.
 Leucid Bio Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biotech company that develops next generation CAR-T therapy | Director/Board Member | - |
| SCANCELL HOLDINGS PLC | Director/Board Member | - |
| ░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Training of Martin Diggle
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
23
1st degree connections
11
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
Proteome Sciences Plc
 Proteome Sciences Plc Medical SpecialtiesHealth Technology Develops medical diagnostics used to identify specific diseases | Health Technology |
Oxford Biomedica Plc
 Oxford Biomedica Plc BiotechnologyHealth Technology Operates as a contract development and manufacturing organization which provides viral vectors to pharmaceutical and biotechnology clients in cell and gene therapy fields | Health Technology |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Brunswick UBS
Brunswick UBS Investment Banks/BrokersFinance Operates as a investment bank | Finance |
Scancell Holdings Plc
 Scancell Holdings Plc BiotechnologyHealth Technology Develops therapeutic cancer vaccines | Health Technology |
Oxford BioDynamics Plc
 Oxford BioDynamics Plc BiotechnologyHealth Technology Discovers and develops novel biomarkers | Health Technology |
Vulpes Investment Management Ltd.
Vulpes Investment Management Ltd. Investment ManagersFinance Provides investment advice | Finance |
Vulpes Life Sciences Fund
Vulpes Life Sciences Fund Investment Trusts/Mutual FundsMiscellaneous Acts as Hedge Fund | Miscellaneous |
Chronos Therapeutics Ltd.
 Chronos Therapeutics Ltd. BiotechnologyHealth Technology Develops therapies in degenerative and behavioral brain diseases | Health Technology |
Vulpes Investment Management Pte Ltd. (Venture Capital)
Vulpes Investment Management Pte Ltd. (Venture Capital) Investment ManagersFinance Vulpes Ventures invests in companies located in Southeast Asia, Australia and New Zealand. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements. | Finance |
Leucid Bio Ltd.
Leucid Bio Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biotech company that develops next generation CAR-T therapy | Commercial Services |
- Stock Market
- Insiders
- Martin Diggle
